217 related articles for article (PubMed ID: 9884673)
21. Developmental pharmacodynamics: implications for child and adolescent psychopharmacology.
Carrey N; Kutcher S
J Psychiatry Neurosci; 1998 Nov; 23(5):274-6. PubMed ID: 9846031
[No Abstract] [Full Text] [Related]
22. Pharmacotherapeutic challenges in treatment of a child with "the triad" of obsessive compulsive disorder, attention-deficit/hyperactivity disorder and Tourette's disorder.
Rice T; Coffey B
J Child Adolesc Psychopharmacol; 2015 Mar; 25(2):176-9. PubMed ID: 25782100
[No Abstract] [Full Text] [Related]
23. Practical clinical issues regarding child and adolescent psychopharmacology.
Kutcher S
Child Adolesc Psychiatr Clin N Am; 2000 Jan; 9(1):245-60. PubMed ID: 10674199
[TBL] [Abstract][Full Text] [Related]
24. When pills make sense. Some parents turn too quickly to mood-altering drugs. But often medication is the right choice.
Sachs A
Time; 2000 Mar; 155(11):F12. PubMed ID: 11009701
[No Abstract] [Full Text] [Related]
25. Clinical issues in child and adolescent psychopharmacology.
Gadow KD
J Consult Clin Psychol; 1991 Dec; 59(6):842-52. PubMed ID: 1774369
[TBL] [Abstract][Full Text] [Related]
26. Challenges in developing drugs for pediatric CNS disorders: A focus on psychopharmacology.
Grabb MC; Gobburu JVS
Prog Neurobiol; 2017 May; 152():38-57. PubMed ID: 27216638
[TBL] [Abstract][Full Text] [Related]
27. Advances in paediatric neuropsychopharmacology: an overview.
March JS; Vitiello B
Int J Neuropsychopharmacol; 2001 Jun; 4(2):141-7. PubMed ID: 11466164
[TBL] [Abstract][Full Text] [Related]
28. Psychopharmacology of the Rage Attack Phenomenon in a Child with Obsessive Compulsive Disorder.
Weiss-Goldman N; Arditi B; Rice T; Coffey BJ
J Child Adolesc Psychopharmacol; 2018 Jun; 28(5):360-362. PubMed ID: 29889566
[No Abstract] [Full Text] [Related]
29. Psychopharmacology in child and adolescent psychiatry: a review of the past five years.
Campbell M; Spencer EK
J Am Acad Child Adolesc Psychiatry; 1988 May; 27(3):269-79. PubMed ID: 3288611
[No Abstract] [Full Text] [Related]
30. Psychotropic medication utilization at a group-home residential facility for children and adolescents.
Handwerk ML; Smith GL; Thompson RW; Spellman DF; Daly DL
J Child Adolesc Psychopharmacol; 2008 Oct; 18(5):517-25. PubMed ID: 18928416
[TBL] [Abstract][Full Text] [Related]
31. Current concepts. Psychopharmacology in children.
Biederman J; Jellinek MS
N Engl J Med; 1984 Apr; 310(15):968-72. PubMed ID: 6142421
[No Abstract] [Full Text] [Related]
32. Period prevalence of concomitant psychotropic medication usage among children and adolescents with attention-deficit/hyperactivity disorder during 2009.
Betts KA; Sikirica V; Hodgkins P; Zhou Z; Xie J; DeLeon A; Erder MH; Wu EQ
J Child Adolesc Psychopharmacol; 2014 Jun; 24(5):260-8. PubMed ID: 24839998
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological treatments of autism, attention deficit hyperactivity disorder, oppositional defiant disorder, and depression in children and youth--commentary.
Werry JS
J Clin Child Psychol; 2001 Mar; 30(1):110-3. PubMed ID: 11294068
[No Abstract] [Full Text] [Related]
34. Prescribing practices of psychiatrists and primary care physicians caring for children with mental illness.
Harpaz-Rotem I; Rosenheck RA
Child Care Health Dev; 2006 Mar; 32(2):225-37. PubMed ID: 16441857
[TBL] [Abstract][Full Text] [Related]
35. Psychopharmacology and Cardiovascular Disease.
Piña IL; Di Palo KE; Ventura HO
J Am Coll Cardiol; 2018 May; 71(20):2346-2359. PubMed ID: 29773162
[TBL] [Abstract][Full Text] [Related]
36. Psychopharmacology for young children: clinical needs and research opportunities.
Vitiello B
Pediatrics; 2001 Oct; 108(4):983-9. PubMed ID: 11581454
[TBL] [Abstract][Full Text] [Related]
37. Psychotropic medication patterns among youth in foster care.
Zito JM; Safer DJ; Sai D; Gardner JF; Thomas D; Coombes P; Dubowski M; Mendez-Lewis M
Pediatrics; 2008 Jan; 121(1):e157-63. PubMed ID: 18166534
[TBL] [Abstract][Full Text] [Related]
38. [Psychostimulants: a potential therapeutic alternative in mood and obsessive compulsive disorders (first part)].
Samain V
Rev Med Brux; 2003 Dec; 24(6):464-9. PubMed ID: 14748179
[TBL] [Abstract][Full Text] [Related]
39. Developments in pediatric psychopharmacology: focus on stimulants, antidepressants, and antipsychotics.
Correll CU; Kratochvil CJ; March JS
J Clin Psychiatry; 2011 May; 72(5):655-70. PubMed ID: 21658348
[TBL] [Abstract][Full Text] [Related]
40. Psychiatric pharmacogenomics in pediatric psychopharmacology.
Wall CA; Croarkin PE; Swintak C; Koplin BA
Child Adolesc Psychiatr Clin N Am; 2012 Oct; 21(4):773-88. PubMed ID: 23040901
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
